# Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke

> **NCT05199194** · PHASE3 · RECRUITING · sponsor: **Hospital Moinhos de Vento** · enrollment: 398 (estimated)

## Conditions studied

- Stroke, Ischemic
- Stroke, Acute

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05199194
- **Lead sponsor:** Hospital Moinhos de Vento
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-27
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 398 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199194, "Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05199194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*